Sight Sciences price target lowered to $5 from $5.50 at UBS
UBS analyst Danielle Antalffy lowered the firm’s price target on Sight Sciences (SGHT) to $5 from $5.50 and keeps a Buy rating on the shares.
Barclays Remains a Buy on Abbott Laboratories (ABT)
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...